Clinical implications of lamivudine resistance by HBV.
Schalm
S W
SW
Department of Hepatogastroenterology, Academic Hospital Dijkzigt, Rotterdam, Netherlands.
D000998:Antiviral Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial / Q000235:genetics; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D007121:Immunocompetence; D019259:Lamivudine / Q000627:therapeutic use*; D017093:Liver Failure / Q000209:etiology / Q000601:surgery; D016031:Liver Transplantation; D009154:Mutation / Q000187:drug effects
D000998:Antiviral Agents; D019259:Lamivudine